H. Adams Iii

Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity

D. Williams, P. L. Rodriguez, N. Pannucci, 2013, Blood Cancer Journal.

CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

G. V. D. van der Windt, A. Kater, E. Eldering, 2020, Journal for immunotherapy of cancer.